Agilent Technologies, Inc. (A) Return on Assets (ROA): 10.24%
Is Agilent Technologies, Inc.’s return on assets (ROA) high or low?
Agilent Technologies, Inc.'s return on assets (ROA) of 10.24% is in line with its 5-year average of 10.55%, around the middle of its 5-year range (7.47%–11.91%).
The return on assets (ROA) for Agilent Technologies, Inc. (A) is 10.24% as of Wednesday, June 10, 2026. It is below its 12-month average by 3.03% (10.56%).
A Return on Assets (ROA) Chart
A Average Return on Assets (ROA) Chart
A Current vs Average Return on Assets (ROA) Chart
A Return on Assets (ROA) Metrics
RETURN ON ASSETS (ROA)
10.24%
RETURN ON ASSETS (ROA) AVG TTM
10.56%
RETURN ON ASSETS (ROA) AVG 3Y
11.14%
RETURN ON ASSETS (ROA) AVG 5Y
10.55%
RETURN ON ASSETS (ROA) AVG 10Y
8.88%
RETURN ON ASSETS (ROA) AVG 15Y
8.67%
RETURN ON ASSETS (ROA) AVG 20Y
9.70%
CURRENT VS TTM AVG
-3.03%
CURRENT VS 3Y AVG
-8.06%
CURRENT VS 5Y AVG
-2.97%
CURRENT VS 10Y AVG
+15.26%
CURRENT VS 15Y AVG
+18.08%
CURRENT VS 20Y AVG
+5.59%
A Competitors' Return on Assets (ROA)
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Agilent Technologies, Inc. (A) | — | 10.24% | 10.56% | 11.14% | 10.55% |
| Zoetis Inc. (ZTS) | $34.46B | 17.28% | 17.37% | 16.33% | 15.33% |
| Humana Inc. (HUM) | $43.60B | 2.44% | 2.52% | 4.20% | 5.49% |
| Centene Corporation (CNC) | $32.69B | -8.59% | -2.29% | 0.04% | 0.75% |
| IQVIA Holdings Inc. (IQV) | $31.09B | 4.54% | 4.82% | 4.76% | 4.01% |
| IDEXX Laboratories, Inc. (IDXX) | $45.66B | 31.62% | 29.29% | 27.30% | 27.52% |
| DexCom, Inc. (DXCM) | $30.17B | 13.19% | 11.04% | 9.26% | 8.83% |
| Biogen Inc. (BIIB) | $29.39B | 4.39% | 5.11% | 6.74% | 8.29% |
| Veeva Systems Inc. (VEEV) | $27.37B | 10.12% | 9.93% | 9.72% | 10.43% |
| Waters Corporation (WAT) | $24.19B | 12.66% | 13.34% | 15.53% | 17.15% |
Asset Efficiency
ROA
10.2%
ROE
19.3%
Agilent Technologies, Inc. Return on Assets (ROA) Formula & Definition
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Agilent Technologies, Inc. Return on Assets (ROA) FAQ
- What is the return on assets (ROA) for Agilent Technologies, Inc. (A)?
- The return on assets (ROA) for A stock is 10.24%.
- Is Agilent Technologies, Inc.'s return on assets (ROA) high or low?
- Agilent Technologies, Inc.'s return on assets (ROA) of 10.24% is in line with its 5-year average of 10.55%, around the middle of its 5-year range (7.47%–11.91%).
- What is the TTM average return on assets (ROA) for Agilent Technologies, Inc. (A)?
- The TTM average return on assets (ROA) for A stock is 10.56%.
- What is the 3Y average return on assets (ROA) for Agilent Technologies, Inc. (A)?
- The 3Y average return on assets (ROA) for A stock is 11.14%.
- What is the 5Y average return on assets (ROA) for Agilent Technologies, Inc. (A)?
- The 5Y average return on assets (ROA) for A stock is 10.55%.
- What is the 10Y average return on assets (ROA) for Agilent Technologies, Inc. (A)?
- The 10Y average return on assets (ROA) for A stock is 8.88%.
- What is the 15Y average return on assets (ROA) for Agilent Technologies, Inc. (A)?
- The 15Y average return on assets (ROA) for A stock is 8.67%.
- What is the 20Y average return on assets (ROA) for Agilent Technologies, Inc. (A)?
- The 20Y average return on assets (ROA) for A stock is 9.70%.
Agilent Technologies, Inc. Return on Assets (ROA) History
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-10-31 | 10.24% |
| 2024-10-31 | 10.88% |
| 2023-10-31 | 11.52% |
| 2022-10-31 | 11.91% |
| 2021-10-31 | 11.30% |
| 2020-10-31 | 7.47% |
| 2019-10-31 | 11.33% |
| 2018-10-31 | 3.70% |
| 2017-10-31 | 8.12% |
| 2016-10-31 | 5.90% |
| 2015-10-31 | 5.36% |
| 2014-10-31 | 5.08% |
| 2013-10-31 | 6.78% |
| 2012-10-31 | 10.94% |
| 2011-10-31 | 11.17% |
| 2010-10-31 | 7.05% |
| 2009-10-31 | -0.41% |
| 2008-10-31 | 9.89% |
| 2007-10-31 | 8.45% |
| 2006-10-31 | 44.88% |
| 2005-10-31 | 2.09% |
| 2004-10-31 | 5.17% |
| 2003-10-31 | -32.68% |
| 2002-10-31 | -12.58% |
| 2001-10-31 | 2.10% |
| 2000-10-31 | 9.09% |
| 1999-10-31 | 9.40% |
| 1998-10-31 | 5.15% |
Related Metrics
About Agilent Technologies, Inc.
Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Padraig McDonnell